Academic Journal

Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study

التفاصيل البيبلوغرافية
العنوان: Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study
المؤلفون: Sufang Wei, Meixin Hu, Hongjie Chen, Qiuli Xie, Peng Wang, Hong Li, Jie Peng
المصدر: BMC Gastroenterology, Vol 22, Iss 1, Pp 1-8 (2022)
بيانات النشر: BMC, 2022.
سنة النشر: 2022
المجموعة: LCC:Diseases of the digestive system. Gastroenterology
مصطلحات موضوعية: Chronic hepatitis B, Hepatitis B virus DNA, Alanine aminotransferase, Nucleoside/nucleotide analogues, FibroScan, Diseases of the digestive system. Gastroenterology, RC799-869
الوصف: Abstract Background There are inadequate data and no histological evidence regarding the effects of antiviral treatment for hepatitis B e-antigen (HBeAg)-negative chronic hepatitis B (CHB) patients with normal or mildly elevated alanine aminotransferase (ALT). This study investigated the effects of antiviral treatment on these patients. Methods We retrospectively analysed the outcomes of antiviral treatment for HBeAg-negative CHB patients with normal or mildly elevated ALT who were treated with nucleoside/nucleotide analogues (NAs) for up to 96 weeks. Results A total of 128 patients were enrolled; 74 patients had normal ALT and 54 patients had mildly elevated ALT. The total cumulative rates of viral suppression were 64.06%, 81.97%, and 96.39%, at weeks 24, 48, and 96, respectively. The cumulative rates of viral suppression for the normal and mildly elevated ALT groups were 67.85% and 58.97%, 86.39% and 76.31%, and 93.13% and 97.04% at weeks 24, 48, and 96, respectively. The serum HBV DNA levels at week 12 and hepatitis B surface antigen (HBsAg) levels at week 24 were significant predictors of the 96-week virological response. Of the 128 patients, 54 with normal ALT and 33 with mildly elevated ALT underwent FibroScan at baseline. Significant fibrosis (F ≥ 2) was found in 44.4% (n = 24) and 51.5% (n = 17) of the patients in the normal ALT group and mildly elevated ALT group, respectively. Compared with the values at baseline, liver stiffness values significantly decreased at week 48 (8.12 kPa vs. 6.57 kPa; p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-230X
Relation: https://doaj.org/toc/1471-230X
DOI: 10.1186/s12876-022-02471-y
URL الوصول: https://doaj.org/article/e6e7491fccb74974a7bf35371373886f
رقم الانضمام: edsdoj.6e7491fccb74974a7bf35371373886f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1471230X
DOI:10.1186/s12876-022-02471-y